Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

CORRECTION - Blocklisting Update

15 Dec 2022 07:00

RNS Number : 7633J
Thruvision Group PLC
15 December 2022
 

RNS

15 December 2022

Thruvision Group plc

 

("Thruvision" or the "Company")

 

Blocklisting update

 

Correction to the first paragraph of the announcement made at 07:00 (RNS number: 4546J) on 13 December 2022: the number of ordinary shares for which an application has been made is 195,650 and not 196,650 as previously mentioned. The full corrected announcement is as per below. All other information was correct.

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market today announces, announces that an application has been made to the London Stock Exchange for the blocklisting of 195,650 ordinary shares of 1p each ("New Ordinary Shares").

 

The New Ordinary Shares will be issued from time to time pursuant to the exercise of employee share options under the Thruvision Group plc Sharesave Scheme.

 

On exercise, these shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares in issue. It is expected that admission will be granted on 16 December 2022.

 

An update to its blocklisting application is given below and on the assumption that the 195,650 shares are admitted on 16 December 2022.

 

 

Name of Company: Thruvision Group plc

 

Name of Scheme: Thruvision Group plc Sharesave Scheme

 

Balance of Ordinary 1p shares under the Nil

Scheme at 8 June 2022:

 

Number of Ordinary 1p shares issued 195,650

under the Scheme during the period:

 

Number of Ordinary 1p shares cancelled Nil

under the scheme during the period:

 

Balance of Ordinary 1p shares under the 195,650

Scheme at 15 December 2022:

 

At 15 December 2022 the total number of Ordinary Shares in issue with voting rights is 147,165,718.

 

No Ordinary Shares are held in treasury.

 

The above figure of 147,165,718 Ordinary Shares in the Company carrying voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

For further information please contact:

 

Thruvision Group plc

+44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

Investec Investment Banking (NOMAD & Broker)

+44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

FTI Consulting LLP

+44 (0)20 3727 1000

Matt Dixon / Tom Blundell

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford and Washington DC.

 

 

www.thruvision.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSBKQBNKBDBFBD
Date   Source Headline
28th Feb 20258:38 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
26th Feb 20253:16 pmRNS-RNew product launch
18th Feb 202512:45 pmGNWForm 8.3 - [THRUVISION GROUP PLC- 17 02 2025] - (CGAML)
18th Feb 20258:00 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
17th Feb 202511:21 amGNWForm 8.3 - [THRUVISION GROUP PLC- 14 02 2025] - (CGAML)
17th Feb 202511:14 amRNSForm 8.3 - Thruvision Group plc
17th Feb 20258:27 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
14th Feb 202512:02 pmRNSForm 8.3 - Thruvision Group plc
14th Feb 20259:09 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
13th Feb 20257:00 amRNSTrading update and Progress on Strategic Review
7th Feb 20252:08 pmRNSForm 8.3 - Thruvision Group PLC
7th Feb 202512:14 pmRNSHolding(s) in Company
7th Feb 202510:52 amRNSForm 8.3 - Thruvision Group plc
7th Feb 20258:17 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
6th Feb 20255:05 pmRNSForm 8.3 - Thruvision Group PLC
6th Feb 202512:08 pmRNSForm 8.3 - Thruvision Group PLC
6th Feb 202510:43 amRNSRule 8.3 - Thruvision Group PLC
4th Feb 202512:06 pmRNSForm 8.3 - Thruvision Group PLC
30th Jan 202510:58 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
29th Jan 202511:38 amRNSForm 8.3 - Thruvision Group plc
24th Jan 20256:00 pmRNSForm 8.3 - Thruvision Group plc
23rd Jan 20251:53 pmRNSForm 8.3 - Thruvision Group PLC
22nd Jan 20255:03 pmRNSForm 8.3 - Thruvision Group PLC
21st Jan 20251:56 pmRNSForm 8.3 - Thruvision Group PLC
20th Jan 202512:12 pmRNSForm 8.3 - Thruvision Group PLC
20th Jan 20257:00 amRNSForm 8.3 - Thruvision Group plc
17th Jan 202512:11 pmRNSForm 8.3 - Thruvision Group plc
16th Jan 202511:29 amRNSForm 8.3 - Thruvision Group plc
15th Jan 20255:38 pmRNSForm 8 (OPD) - Thruvision Group plc
15th Jan 20251:12 pmGNWForm 8.3 - [THRUVISION GROUP PLC - Opening Disclosure - 14 01 2025] - (CGAML)
15th Jan 202512:58 pmGNWInvesco Ltd: Form 8.3 -Thruvision Group PLC; Opening position disclosure
15th Jan 202512:09 pmRNSForm 8.3 - Thruvision Group PLC
15th Jan 202511:42 amRNSForm 8.3 - Thruvision Group plc
15th Jan 202511:05 amRNSForm 8.3 - Thruvision Group Plc
15th Jan 20258:53 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
14th Jan 20257:00 amRNSStrategic Review
30th Dec 20247:00 amRNSAppointment of Chief Executive Officer
13th Dec 202412:38 pmRNSSharesave option grant to Executive Director
20th Nov 202410:45 amRNSBlocklisting update
20th Nov 202410:41 amRNSBlocklisting update
18th Nov 202410:50 amRNSAward of Share Options to Executive Director
15th Nov 20245:00 pmRNSHolding(s) in Company
14th Nov 202412:34 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSIssue of Equity
24th Oct 20247:00 amRNSInterim Results
14th Oct 20247:00 amRNSHalf year trading update and Board changes
19th Sep 202411:50 amRNSResult of AGM
28th Jun 20247:00 amRNSFinal Results
12th Jun 20247:00 amRNSResults notification
3rd Jun 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.